Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 10/20 | 0.46 |
| ▸ | PTGES | O14684 | 4/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.41 |
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | PPARA | Q07869 | 3/20 | 0.41 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5372818 | 0.81 | TBXA2R (0.46) | TBXA2RPTGESALOX5PPARGPPARA | |
| SCHEMBL27517899 | 0.80 | TBXA2R (0.45) | TBXA2RFFAR1 | |
| SCHEMBL5403733 | 0.78 | TBXA2R (0.44) | TBXA2RFFAR1 | |
| SCHEMBL5442371 | 0.78 | TBXA2R (0.47) | TBXA2RPPARGPPARAPPARDFFAR1 | |
| SCHEMBL4452562 | 0.78 | TBXA2R (0.47) | TBXA2RPPARGPPARAPPARDFFAR1 | |
| SCHEMBL18408651 | 0.76 | PTGDR2 (0.53) | TBXA2RPPARGPPARDFFAR1 | |
| Cyhalofop-Butyl SCHEMBL29395915 | 0.76 | GAA (0.47) | TBXA2RFFAR1 | |
| Cyhalofop-Butyl SCHEMBL28218726 | 0.76 | GAA (0.47) | TBXA2RFFAR1 | |
| Cyhalofop-Butyl SCHEMBL56020 | 0.76 | GAA (0.47) | TBXA2RFFAR1 | |
| Cyhalofop-Butyl SCHEMBL28275004 | 0.76 | GAA (0.47) | TBXA2RFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2005-09-01 | — | — | US | claimed |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | BAYER CROPSCIENCE AG (GB) | 2005-04-28 | — | — | US | claimed |
| US-20040116294-A1 | Herbicides based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2004-06-17 | — | — | US | claimed |
| US-7202196-B2 | Selective herbicide comprising a tetrazolinone derivative | BAYER CROPSCIENCE AG (DE) | 2007-04-10 | — | — | US | disclosed |
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2005-09-01 | — | — | US | disclosed |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | BAYER CROPSCIENCE AG (GB) | 2005-04-28 | — | — | US | disclosed |
| US-20050085388-A1 | Selective herbicide comprising a tetrazolinone derivative | BAYER CROPSCIENCE AG (DE) | 2005-04-21 | — | — | US | disclosed |
| US-20040116294-A1 | Herbicides based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | DDT, CBR3, CYP1B1 | TBXA2R 4210/4885PTGES 2839/4885ALOX5 4194/4885 |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | DDT, CBR3, CBR1 | TBXA2R 3852/4885PTGES 3361/4885ALOX5 4079/4885 |
| US-20050085388-A1 | Selective herbicide comprising a tetrazolinone derivative | DDT, DYRK4, DYRK3 | TBXA2R 3159/4885PTGES 2927/4885ALOX5 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.